Does Huawei's blood pressure smartwatch Watch D really work? A heart patient tells you first hand

I'm a heart patient who uses a Huawei smart health device. In this article, I will combine my real use experience, to tell you about the Huawei watch health monitoring function in the end is not useful.

Recently, foreign media exposed Huawei to the European Intellectual Property Office (EUIPO) applied for registration of the "Huawei Watch D" trademark, the trademark category for 9/10/14, covering instruments used for medical analysis, heart rate monitoring, smartwatches, body fat detection, as well as blood pressure monitors! "Sphygmomanometer" is the more specific element.

According to a previous release by Huawei executive He Gang, Huawei is currently working on a wearable blood pressure measurement device, and has already made a breakthrough in the technology.

The device is said to have home medical-grade high-precision blood pressure measurement as its core goal, and Huawei has launched a hypertension management study with a well-known domestic organization to explore the establishment of an innovative active health management system for blood pressure from screening to early intervention.

I'm currently using the Huawei Watch GT 2 Pro ECG Edition, which is Huawei's first smart wearable to receive the State Drug Administration's Class II Medical Device Registration Certificate.

I myself happen to be a coronary artery disease patient, and this watch has a great deal to offer in terms of "arrhythmia detection," "apnea research," and "vascular health research. " have a big role to play.

In addition, the data collected by the ECG model's sensors, fused with PPG and AAC data for comprehensive analysis, has the ability to coronary heart disease intelligent screening and early warning capabilities, for the high-risk group of people with heart disease for heart disease "secondary prevention", has a very good role.

In addition, Huawei's smart wearables have 24-hour heart rate, oxygen saturation, sleep, and stress monitoring and other specialized health management capabilities. The collected health data can also be submitted to professional organizations for interpretation. For example, it can be added to the 301 Hospital's Heart Health Study to help with early risk screening for atrial fibrillation, premature contractions, sleep apnea risk screening, and more.

The data above are the premature beats I'm currently monitoring with my GT2 Pro ECG, as well as my 24hr daily heart disease risk prediction data.

These are the data from the ECG function for electrocardiograms and vascular elasticity. (The ECG data jittered badly because I had to move my wrist to take a screenshot)

I just had heart surgery in November 2020, and I'm still having "premature ventricular contractions" and other problems. The Huawei Watch correctly recognizes my premature beats.

I have regular ECGs at the hospital, and I automatically monitor my premature beats throughout the day with the Huawei Watch GT2 Pro ECG's cardiac monitoring feature, which allows me to deduce my recent cardiac health from changes in the data. The watch itself also has a risk prediction function, which can predict your heart risk 24Hr throughout the day. If necessary, you can go to the hospital in time for a checkup.

In addition, heart disease patients usually suffer from blood pressure problems, either high blood pressure or low blood pressure from medication or exercise. If the smartwatch is able to monitor blood pressure, it will be a more practical function.

It's just not clear whether the Huawei Watch D can support both ECG monitoring and blood pressure monitoring. If it can support both, it would be perfect, and I'd be the first to buy and use it.

It is said that the Huawei Watch D blood pressure watch has passed the medical device registration inspection, and has already opened the registration clinical trial jointly with a professional medical organization, and is expected to be on the market before the end of the year.

Huawei's deep plowing in the smart health wearable field is serious!







The newest addition to our portfolio is the newest addition to our portfolio, the newest addition to our portfolio. We have no reason to worry about whether or not the products they test and develop will work!